Clinical Trial Product
Payments companies reported to CMS as associated with Clinical Trial Product. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Clinical Trial Product, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Clinical Trial Product
These are the largest totals companies reported as associated with Clinical Trial Product. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Paul Underwood | Scottsdale, AZ | Cardiovascular Disease | $122,625.00 |
| Michael Mcdonald | Celebration, FL | Urology | $64,250.00 |
| Deepak Bhatt | New York, NY | Interventional Cardiology | $57,420.00 |
| Kenneth Rosenfield | Boston, MA | Cardiovascular Disease | $47,190.11 |
| Alejandro Rabinstein | Rochester, MN | Neurology (Psychiatry & Neurology) | $43,062.50 |
| Robert Taylor | Oxnard, CA | Neurological Surgery | $40,137.50 |
| Suneet Mittal | Paramus, NJ | Clinical Cardiac Electrophysiology | $30,997.50 |
| Michael Manoles | Minneapolis, MN | Interventional Cardiology | $29,675.00 |
| Dina Sparano | Mayfield Heights, OH | Clinical Cardiac Electrophysiology | $29,287.50 |
| David Hurrell | Minneapolis, MN | Cardiovascular Disease | $29,062.50 |
Prescribed Clinical Trial Product?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.